000			01970 a2200553 4500
005			20250514051156.0
264		0	_c20021108
008			200211s 0 0 eng d
022			_a1524-4563
024	7		_a10.1161/01.hyp.0000036451.76323.29 _2doi
040			_aNLM _beng _cNLM
100	1		_aRoig, Francisco
245	0	0	_aRole of cyclooxygenase-2 in the prolonged regulation of renal function. _h[electronic resource]
260			_bHypertension (Dallas, Tex. : 1979) _cNov 2002
300			_a721-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAldosterone _xblood
650	0	4	_aAnimals
650	0	4	_aBlood Flow Velocity _xdrug effects
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCyclooxygenase 2
650	0	4	_aCyclooxygenase 2 Inhibitors
650	0	4	_aCyclooxygenase Inhibitors _xpharmacology
650	0	4	_aDogs
650	0	4	_aFemale
650	0	4	_aGlomerular Filtration Rate _xdrug effects
650	0	4	_aInfusions, Intravenous
650	0	4	_aIsoenzymes _xantagonists & inhibitors
650	0	4	_aKidney _xblood supply
650	0	4	_aKidney Function Tests
650	0	4	_aModels, Animal
650	0	4	_aNitric Oxide _xmetabolism
650	0	4	_aPotassium _xblood
650	0	4	_aProstaglandin-Endoperoxide Synthases _xmetabolism
650	0	4	_aProstaglandins _xurine
650	0	4	_aRenal Circulation _xdrug effects
650	0	4	_aRenin _xblood
650	0	4	_aSodium _xblood
650	0	4	_aSodium Chloride _xadministration & dosage
650	0	4	_aSodium, Dietary _xpharmacology
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aTime Factors
650	0	4	_aVasoconstriction _xdrug effects
700	1		_aLlinás, Maria T
700	1		_aLópez, Ruth
700	1		_aSalazar, F Javier
773	0		_tHypertension (Dallas, Tex. : 1979) _gvol. 40 _gno. 5 _gp. 721-8
856	4	0	_uhttps://doi.org/10.1161/01.hyp.0000036451.76323.29 _zAvailable from publisher's website
999			_c12219538 _d12219538